View by type:
Documents (9899)
.......
GAVI Alliance Audit and Finance Committee Meeting
25 July 2012
AFC-2012-Mtg-02 1
GAVI Alliance Audit and Finance Committee Meeting
25 July 2012
Teleconference
FINAL MINUTES
Finding a quorum of members present, the meeting co mmenced at 10.00
Washington time on 25 July 2012. Wayne Berson, Audi t and Finance Committee
Chair, chaired the meeting. Standing declarations o f interest were tabled to the
Committee (Doc 3a in the Committee pack).
1. Executive session with the external auditor
1.1 The Committee held an executive session with Ma rianne Fallon, Pierre-Henri
Pingeon, and Karina Vartanova from KPMG, GAVI?s ext ernal auditor to
discuss the conduct of the 2011 audit (Doc 1). The Committee invited Cees
Klumper, Director of Internal Audit to attend.
1.2 At 10.40, the Committee convened in open sessio n.
Report out of executive session
The Chair summarised for the minutes the outcomes of the executive session.
The Committee had discussed a difference in opinio n between GAVI and
KPMG with regard to the methodology used to value A MC pledges. The Chair
reported that in his opinion, and that of another ? Big Four? accounting firm, the
valuation method GAVI had used, which KPMG had acce pted during the past
two years, continued to be the appropriate one, and questioned why KPMG
was advocating a change even though the applicable accounting standards
had not changed. Consequently, before recommending the 2011 annual
financial report to the Board, the Committee reques ted that KPMG clarify:
o Why KPMG?s new position on the methodology was cor rect and why
GAVI?s current position was incorrect, and
o On what basis KPMG had approved the methodology in previous years
and why it changed its position from this previousl y approved
methodology. Derek Strocher from the World Bank off ered to work with
the Secretariat to resolve this issue with KPMG.
The Committee had discussed KPMG?s characterisatio n of two immaterial
employee benefit issues that had been detected and resolved by the
Secretariat. Whilst KPMG noted they had been approp riately handled, the
EAC Mtg Final Minutes 5 July 2012
Evaluation Advisory Committee Meeting
5 July 2012
EAC -2012 -Mtg -3a 1
GAVI Alliance Evaluation Advisory Committee Meeting
5 July 2012
Geneva, Switzerland
FINAL MINUTES
1. Chair?s report
1.1 Finding a quorum of members present, the meeting commenced at 09.45
Geneva time on 5 July 2012. Sania Nishtar , Committee Chair, participating by
videoconference, chaired the meeting. Rob Moodie co -chaired.
1.2 Standing declarations of interest were tabled to the Committe e (Doc 1a ). Alan
Hinman noted that the Novartis research grant reported was for rabies rather
than measles.
1. 3 The Committee noted the minutes of its meeting of 19 -20 January 2012 in
Geneva (Doc 1b) and its teleconference of 13 February 2012 (Doc 1c) .
The se minutes were approved by no objection on 23 April 201 2.
1.4 The Chair updated the EAC on the GAVI Alliance Board meeting which had
taken place in Washington D.C. in June 2012 and at which she had reported
on the activities of the EAC. The Board had approved the Evaluation Policy
and considered the EAC engagement with the evaluation of GAVI support to
CSOs as quite productive. She had updated the Board on the EAC?s role in
reviewing and approving the Request for Proposals for the Advance Market
Commit ment for Pneumococcal Vaccine Process and Design Evaluation , as
well as the process in relation to the Full Country Evaluations.
1.5 During a short meeting with Dagfinn H ?ybr ?ten, GAVI Alliance Board Chair,
the EAC Chair had briefly discussed the w ork of the EAC feeding into policy
as well as the changing landscape of health with respect to the post MDG
landscape. A short discussion on the latter is recorded under Item 9.
--- ---
2. Update from the Secretariat
2.1 Nina Schwalbe, Managing Director, Policy and Performance, reported to the
EAC that the Secretariat has been working on updating the mission indicators
and that the Board has been provided with progress reports on Key
Performance Indicators and the GAVI All iance risk register.
GAVI Alliance Board Meeting
12 -13 June 2012
Capital Hilton Hotel, Washington, DC, USA
Sunday 10 and Monday 11 June: Pre -Board meetings
Tuesday 12 June: 09.00 -17. 30 (Board meeting Day One)
Wednesday 13 June: 08.30 -17.00 (Board meeting Day Two)
Thursday 14 June: Post -Board meetings
Document list
Number DOCUMENT
00a - Document list
00b - Agenda
01a - Declarations of interest
01b - Minutes from 16 -17 November 2011
01c - Minutes from 12 April 2012
01d - Action sheet
01e - Board workplan
01f - Consent agenda: Board and Committee member appointments
01g - Consent agenda: Ethics and Conflicts of Interest Policies
01h - Consent agenda: Evaluation Policy
02 - CEO?s report (To follow)
03 - Committee Chair reports - No paper
04 - Financial forecast
05 - Report of the internal auditor
06 - Amendment to the Programme Funding Policy
07 - Business planning process and risk management update
08 - Amendments to Statutes and By -Laws
09 - Chair?s reflections on the day ? No paper
10 - Chair's overview - No paper
11 - Committee Chair reports - No paper
12 - Options for enhancing GAVI's investment in measles prevention
13 - Vaccine introduction grants and operational support for campaigns
14 - Continued funding for special studies
15 - Programme update: Accelerated Vaccine Introduction (To follow)
16 - Country presentation ? No paper
17 - GAVI support to Civil Society Organisations
18 - Long -term funding strategy
19 - IFFIm report - No paper
20 - IFFIm/GAVI Fund Affiliate restructuring
A - India strategy update (For information only)
B - Programme update : country programmes (For information only )
GAVI Alliance Board Meeting
12-13 June 2012
Capital Hilton Hotel, Washington, DC, USA
Sunday 10 and Monday 11 June : Pre -Board meetings
Tuesday 12 June : 09.00 -17.30 (Board meeting Day One)
Wednesday 13 June : 08.30 -17.00 (Board meeting Day Two)
Thursday 14 June: Post -Board meetings
Quorum: 14
Agenda
Pre -Board Meetings ? Su nday , 10 June 2012
Item Subject Room Schedule
Coffee available Congressional 14 .00 -16.00
Pre -Board meeting
? GAVI Donors meeting
Congressional
14 .00-16.00
Pre -Board Meetings ? Monday, 11 June 2012
Item Subject Room Schedule
Coffee available Outside
Congressional
10.45 -11.30
Pre -Board meetings
? Technical briefing
? GAVI Donors meeting
? All Chairs meeting
Congressional
Congressional
Michigan
8.30 -10. 00
10.00 -13.00
TBD
Lunch for all participants Outside
Congressional
12.45 -13.45
? New Board members meeting hosted by the Chair
? Unaffiliated Board members briefing
? Developing Countries Constituency meeting
Ohio
Ohio
Federal
14.00 -15.00
15.00 -16.30
15.30 -16.30
Coffee available Outside
Congressional
16.30 -17.00
? Closed Executive Session Federal 17.00 -19.30
01a Declarations of interest pdf
GAVI Alliance Board Meeting
12 -13 June 2012
Capital Hilton Hotel, Washington, DC, USA
Sunday 10 and Monday 11 June: Pre -Board meetings
Tuesday 12 June: 08.30 -17.45 (Board meeting Day One)
Wednesday 13 June: 08.30 -17.00 (Board meeting Day Two)
Thursd ay 14 June: Post -Board meetings
Quorum: 1 4
Declarations of interes t
Declarations
Section 4 of the Conflict of Interest Policy states, ?Each member of the Board (including
Alternate Board Members and Committee Delegates)...shall complete and submit an a nnual
statement disclosing interests. ? The following declarations were made by members of the
Board present at this meeting on their most recent annual statements :
Member Organisational Interests Financial/ Personal /Advise r Int
Dagfinn H?ybr?ten, Chair None GAVI -appointed special advis er
Geeta Rao Gupta, Vice Chair UNICEF GAVI -appointed special advis er
Cristian Baeza World Bank None
Amie Batson USAID (USA/CAN/AUS/JPN/KOR) Johns Hopkins University (Family)
Wayne Berson None GAVI Fund Affiliate (Board)
Simon Bland UK (UK/NOR/IRL Donors) TBD
Dwight Bush None None
Flavia Bustreo WHO TBD
H.R.H. the Infanta Cristina of Spain None ?la Caixa? Foundation (Employee)
Barcelona Inst. for Global Health (Board)
Suraya Dalil Go vernment of Afghanistan TBD
Mahima Datla Dev. Ctry. Vaccine Manu. Net. Biological E Limited (Employee)
Christopher Elias Bill & Melinda Gates Foundation TBD
Maria C. Freire None TBD
Ashutosh Garg None None
Guillermo Gonz?lez Government of Nicaragua GAVI -appointed special advis er
Gustavo Gonzalez -Canali France (FRA/EC/LUX/GER Donors) None
A.F.M. Ruhal Haque Government of Bangladesh GAVI -appointed special advis er
Alan Hinman Task Force for Global Health
(CSO constituency ) Novartis ( Research grant - Measles)
Yifei Li None TBD
Anders Nordstr?m Sweden (NED/SWE/DEN Donors) None
01b Minutes from 16 17 November 2011 pdf
GAVI Alliance Board Meeting
16-17 November 2011
Board-2012-Mtg-2-Doc 01b 1
GAVI Alliance Board Meeting
16-17 November 2011
Dhaka, Bangladesh
FINAL MINUTES
1. Chair?s report
1.1 Finding a quorum of members present, the meetin g commenced at 9.03
Dhaka time on 16 November 2011. Dagfinn H?ybr?ten, Board Chair, chaired
the meeting.
1.2 The Chair welcomed new Board members and altern ates, Her Royal
Highness Princess Cristina of Spain, and members of the board of the
International Finance Facility for Immunisation (IF FIm). Also, he thanked the
Ministry of Health of Bangladesh for hosting the me eting and the Secretariat
Governance team and local staff of BRAC, WHO, and U NICEF for their
assistance. He cited this as a good example of the GAVI partnership at work.
1.3 The Chair summarised the outcomes of the execut ive session of the Board
held on 15 November 2011: He noted that the process for constructing the
2012 budget had been extraordinary given the change in Secretariat
leadership and committed that the 2013 process woul d be more ordinary,
starting with Executive Committee consultation. Ne xt, he highlighted work to
be done on managing conflicts of interest, includin g clarifying the role of the
vaccine industry in GAVI?s governance. There had be en good dialogue and
proper management of conflicts to date, but the Boa rd needs an agreed-upon,
comprehensive philosophy that can be clearly articu lated to the public. The
Board also discussed roles and responsibilities of the Board, Secretariat and
Alliance partners, and agreed to have a full discus sion at its 2012 retreat.
Finally, the Board received an update from Cees Klu mper, Director of Internal
Audit, on investigations of misuse in recipient cou ntries.
1.4 The Chair reflected on remarks made the previou s evening by Ban Ki-moon,
Secretary General of the United Nations, to the GAV I Board. The Chair
recognised Seth Berkley, Chief Executive Officer, c ommenting on his
determined and enthusiastic start. He also highligh ted Sweden?s positive
assessment of GAVI, noting Sweden?s recently releas ed review that stated
that GAVI is highly relevant to its development coo peration and that GAVI?s
internal and external effectiveness is very high.
1.5 Standing declarations of interest were tabled t o the Board (Doc 01a in the
Board pack). In addition, Ronald Brus reported that given Crucell?s purchase
01c Minutes from 12 April 2012 pdf
GAVI Alliance Board Meeting
12 April 2012
Board-2012-Mtg-1 1
GAVI Alliance Board Meeting
12 April 2012
Teleconference
FINAL MINUTES *
1. Chair?s report
1.1 Finding a quorum of members present, the meetin g commenced at 16.06
Geneva time on 12 April 2012. Dagfinn H?ybr?ten, Bo ard Chair, chaired the
meeting.
1.2 The Chair reminded the Board that the Executive Committee was originally
scheduled to meet at this time to consider funding new programmes.
However, he wanted the Board nominees to participat e as equals at the
forthcoming retreat, which necessitated a Board dec ision to appoint them. He
noted that each agenda item at this meeting had bee n reviewed and
recommended at committee level and that the Board c ould take comfort from
those reviews. The Chair also welcomed Board member s elected in Dhaka to
their first Board session.
1.3 Subsequently, standing declarations of interest were tabled to the Board (Doc
1 in the Board pack). ------
2. Programme funding approvals/forecasting
2.1 Bakhuti Shengalia, Director of Technical Suppor t, reviewed the outcomes and
recommendations of the New Vaccine Support and Heal th Systems Funding
Platform Independent Review Committees (IRC), and s ought the Board?s
approval of the recommendations (Doc 2b). The Secre tariat also tabled an
updated financial forecast for 2012-2016, and asked the Board to endorse
multi-year programme budgets in the amount of US$ 5 12,083,141 and near-
term programme liabilities in the amount of $141,61 8,440 (Doc 2a).
2.2 Further, on 11 April 2012, the Audit and Financ e Committee noted that it
reviewed the financial implications of the Programm e Funding Plan contained
within Doc 2a, and that it could be approved by the Board in accordance with
the Programme Funding Policy.
* These minutes were circulated for no-objection ap proval on 21 May 2012, and will become final should no
objections be received by the end of 31 May.
Board -201 2-Mtg -2-Doc 01d
GAVI Alliance Board Meeting
12 -13 June 2012
Capital Hilton Hotel, Washington, DC, USA
Sunday 10 and Monday 11 June: Pre -Board meetings
Tuesday 12 June: 08.30 -17.45 (Board meeting Day One)
Wednesday 13 June: 08.30 -17.00 (Board meeting Day Two)
Thursd ay 14 June: Post -Board meetings
Quorum: 1 4
Action sheet
Item Request Matter Responsible Status
1
16 -17 Nov
2011; ? 4
OPTIONS PAPER ? MAXIMISING OUTCOMES
The Board reiterated its request that the Secretariat
develop an options paper for the April 2012 Board
Retreat on how to maximise outcomes from GAVI
investments. The outline of the paper should be
circulated prior to the Retreat so there is common
ownersh ip of the subject. In terms of content, the paper
should cover broadly: where we are today (costs,
results); expected results in the future; options for
maximising outcomes (increased coverage, reaching
the last 20%, increased focus on countries, new
vacci nes, what additional resources can achieve,
identification of efficiencies, and possible investment in
Measles); and return on investment (in terms of
financial and economic impact on countries, as well as
the possibility of tracking data not just on morta lity but
also on morbidity).
Secretariat
(Berkley)
Done
2
16 -17 Nov
2011; ??
13, 14
CASH BASED PROGRAMMES
? The Board requested the Secretariat to roll out the
performance based health systems funding in
accordance with the design summarised in Annex
1 of the report (Doc 13) starting in 2012 for
countries to use as their existing cash support
elapses.
? The Board requested the Sec to create a standing
mechanism to engage partners and technical
experts to proactively steer and coordinate work
and share lessons on health systems
strengthening and other cash based support going
forward.
? The Board requested the Sec to develop a policy that
clearly defines GAVI?s approach to fragile and under -
performing countries.
? The Board requested the Sec to engag e with
partners in developing the performance based
funding assessment tools and encourage them
when needed to provide technical support.
PPC;
Secretariat
(Evans,
Schwalbe ,
Greene ,
Ahun);
TAP
(Klumper)
In
progress
In
progress
In
progress
In
progress